简体中文 | 繁體中文 | English

Products & Services News

2024-04-11 14:19 LTIMindtree Introduces Composable Storefront Solution on Salesforce to Quick-Launch Digital Commerce Experiences
2024-04-11 11:44 Maxon One Spring 2024 Release Packs Particle Power, Toon Shading, and More
2024-04-11 11:17 PUMA Launches Major Brand Campaign to Strengthen Sports Performance Positioning
2024-04-11 11:01 McKay Brothers Launches Fastest London-Stockholm Private Bandwidth
2024-04-10 18:51 Thales and Intel Enable Advanced Protection for the Google Cloud Ecosystem
2024-04-10 18:48 Black Hat Asia 2024: Full Schedule Programming for Singapore Event
2024-04-10 15:27 Neuron Launches Network APIs to Enable Application-Driven QoE On Demand for the Maritime Industry
2024-04-10 15:20 Trinseo Introduces Groundbreaking Flame-retardant Plastic Grades Without Using PFAS Additives During Manufacturing Process
2024-04-10 15:16 ExaGrid’s Q1 2024 Momentum Press Release
2024-04-10 13:46 Welcome to TeKnowledge: Accelerating Progress. Securing Futures.
2024-04-10 13:37 Quectel Introduces Versatile BG95-S5 NTN Satellite Communication Module
2024-04-10 13:34 VeriSilicon Showcased Its Latest Power-Efficient IP Applications at Embedded World 2024
2024-04-10 13:25 NetApp Wins Google Cloud Technology Partner of the Year Award for Infrastructure - Storage
2024-04-10 13:21 Innovation Meets Regulation: International Webinar Explored Effective Anti-Smoking Strategies
2024-04-10 13:17 Boomi World 2024 User Conference to Feature Deion “Coach Prime” Sanders
2024-04-10 11:34 FluxSwiss and SwissAI Collaborate on AI-enabled System Modelling for the Energy Infrastructure
2024-04-10 09:46 Wasabi Technologies Introduces Wasabi AiR™, Pioneering Intelligent Media Storage for Sports, Media and Entertainment Industries
2024-04-09 19:22 Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring
2024-04-09 13:59 Quincy Data Distributes the Lowest Latency Market Data Between New Jersey and Toronto-TMX
2024-04-09 13:52 Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints

Business Wire Weibo

Press Releases

Latest Releases